These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33407199)

  • 1. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review.
    Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z
    BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
    Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.
    Wang X; Liang Y; Yang Y; Li W; Wang G; Wang S; Li Y; Zhang M
    J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
    Chen CC; Chang KC; Medeiros LJ; Lee JY
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
    Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
    [No Abstract]   [Full Text] [Related]  

  • 6. [Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes].
    Umeki Y; Ikeda M; Nakahara W; Asako M; Matsuoka Y; Terakawa T; Matsunaga H; Tadokoro R; Sekiguchi M; Matsui T; Oka K; Higuchi K; Sawada A; Inoue M; Ueda S
    Rinsho Ketsueki; 2023; 64(3):209-213. PubMed ID: 37019675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
    Hirai Y; Asada H; Hamada T; Kawada JI; Kimura H; Arai A; Ohshima K; Ohga S; Iwatsuki K;
    J Dermatol; 2023 Jul; 50(7):e198-e205. PubMed ID: 37249004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicoprognostic Study of Hydroa Vacciniforme-like Lymphoproliferative Diseases: A Systematic Review.
    Kim YJ; Yang HJ; Won CH; Chang SE; Lee MW; Lee WJ
    Dermatology; 2023; 239(5):700-711. PubMed ID: 37231869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: A case series.
    Garzón E; Dávila-Rodríguez JJ
    Indian J Dermatol Venereol Leprol; 2023; 89(3):403-407. PubMed ID: 33871198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.
    Quintanilla-Martinez L; Ridaura C; Nagl F; Sáez-de-Ocariz M; Durán-McKinster C; Ruiz-Maldonado R; Alderete G; Grube P; Lome-Maldonado C; Bonzheim I; Fend F
    Blood; 2013 Oct; 122(18):3101-10. PubMed ID: 23982171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients.
    Xie Y; Wang T; Wang L
    J Dermatol Sci; 2020 Aug; 99(2):128-134. PubMed ID: 32682634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated hydroa vacciniforme-like lymphoproliferative syndrome: excellent response to antiviral therapy.
    İmren IG; Demirkan N; Çomut E; Duygulu Ş
    Int J Dermatol; 2020 Dec; 59(12):e452-e454. PubMed ID: 32808321
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroa vacciniforme-like Epstein-Barr virus-associated lymphoproliferative disease: a case report.
    Zeng Y; Fu L; Jin H; Sun Q; Wang B
    Pediatr Dermatol; 2012; 29(1):96-100. PubMed ID: 21995788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases.
    Zhang Y; Liu Y; Xu J; Liang Y; Xu Z
    Eur J Dermatol; 2024 Apr; 34(2):144-149. PubMed ID: 38907544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
    Chen CC; Chang KC; Medeiros LJ; Lee JY
    J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
    Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
    Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective study on clinicopathological characteristics of 32 cases.
    Xu W; Tan J; Cai C; Lei L; Cao X; Zhou H; Xu M
    Pediatr Dermatol; 2022 May; 39(3):372-375. PubMed ID: 35194837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.
    Pahlow Mose A; Fisker N; Clemmensen O; Bygum A
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection.
    Grześk E; Kołtan S; Dąbrowska A; Urbańczyk A; Małdyk J; Małkowski B; Bogiel T; Dębski R; Czyżewski K; Wysocki M; Styczyński J
    Front Immunol; 2022; 13():915986. PubMed ID: 35990691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is an Epstein-Barr virus (EBV) associated disease.
    Ordoñez-Parra J; Mejía Cortes M; Tamayo-Buendía MM; Infante Gómez AM
    An Bras Dermatol; 2021; 96(3):388-390. PubMed ID: 33849755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.